1. Home
  2. TNFA vs ZCMD Comparison

TNFA vs ZCMD Comparison

Compare TNFA & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNFA
  • ZCMD
  • Stock Information
  • Founded
  • TNFA 2014
  • ZCMD 2012
  • Country
  • TNFA United States
  • ZCMD China
  • Employees
  • TNFA N/A
  • ZCMD N/A
  • Industry
  • TNFA
  • ZCMD Other Consumer Services
  • Sector
  • TNFA
  • ZCMD Real Estate
  • Exchange
  • TNFA NYSE
  • ZCMD Nasdaq
  • Market Cap
  • TNFA 3.7M
  • ZCMD 3.4M
  • IPO Year
  • TNFA N/A
  • ZCMD 2020
  • Fundamental
  • Price
  • TNFA $1.20
  • ZCMD $1.20
  • Analyst Decision
  • TNFA
  • ZCMD
  • Analyst Count
  • TNFA 0
  • ZCMD 0
  • Target Price
  • TNFA N/A
  • ZCMD N/A
  • AVG Volume (30 Days)
  • TNFA 27.7K
  • ZCMD 15.1K
  • Earning Date
  • TNFA 11-29-2024
  • ZCMD 01-01-0001
  • Dividend Yield
  • TNFA N/A
  • ZCMD N/A
  • EPS Growth
  • TNFA N/A
  • ZCMD N/A
  • EPS
  • TNFA N/A
  • ZCMD N/A
  • Revenue
  • TNFA N/A
  • ZCMD $17,406,104.00
  • Revenue This Year
  • TNFA N/A
  • ZCMD N/A
  • Revenue Next Year
  • TNFA N/A
  • ZCMD N/A
  • P/E Ratio
  • TNFA N/A
  • ZCMD N/A
  • Revenue Growth
  • TNFA N/A
  • ZCMD 1.01
  • 52 Week Low
  • TNFA $1.15
  • ZCMD $1.00
  • 52 Week High
  • TNFA $10.68
  • ZCMD $9.90
  • Technical
  • Relative Strength Index (RSI)
  • TNFA 36.11
  • ZCMD 36.47
  • Support Level
  • TNFA $1.26
  • ZCMD $1.17
  • Resistance Level
  • TNFA $1.44
  • ZCMD $1.28
  • Average True Range (ATR)
  • TNFA 0.13
  • ZCMD 0.09
  • MACD
  • TNFA -0.02
  • ZCMD -0.00
  • Stochastic Oscillator
  • TNFA 7.69
  • ZCMD 6.25

About TNFA TNF PHARMACEUTICALS INC EFFEC

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: